ISSFAL LogoISSFAL - fatty acids, lipids and health studies
Home
Contents
Lipid Matters
Society Matters
Newsletter
Archive
Members Only
Membership Dues
New Website Details
Past Conferences
PUFA Recommendations
Newsletter Archive
PLEFA Hard Copy
PLEFA Link
Poll
Who's Online
We have 35 guests online
CB Login
CB Workflows
Home arrow Contents arrow ISSFAL Policy Statements arrow ISSFAL Policy Statement 3
ISSFAL Policy Statement 3

Table 2. Studies of a-linolenic acid and prostate cancer risk.

 

Outcome measurement design

 

Study/ Reference

 

n

 

Study Design

 

Outcome Measurements

 

Results (association between ALA and PC)

Relative Risk (RR) or Odds Ratio (OR) (95% CI) of Prostate Cancer Incidence

 

P Value

Questionnaire –based

Health Professionals Follow-up Study; Giovannucci et al 1993.

47855 (300 new cases of PC)

Prospective

Validated Food frequency questionnaire

Positive

association

RR 3.43 (1.67-7.04)

0.002

Questionnaire –based

Andersson et al 1996

526 cases

536 controls

Case-Control

Semi-quantitative food frequency questionnaire

 

No association

OR 0.9

NS

Questionnaire –based

Netherlands Cohort Study; Schuurman et al 1999

58279

(642 cases of PC)

Prospective

Self-administrated questionnaire

 

No association

RR 0.76 (0.66-1.04)

0.09

Questionnaire –based

De Stéfani et al 2000

217 cases

431 controls

Case-Control

Food frequency questionnaire

Positive association

OR 3.91 (1.5-10.1)

 

0.001

Questionnaire –based

 

Ramon et al 2000

217 cases

434 controls

Case-Control

Semi-quantitative food frequency questionnaire

 

Positive association

OR 3.1 (2.2-4.7)

0.001

Questionnaire and serum –based

 

Physicians’ Health Study; Gann et al 1994

120 men with PC, 120 controls of 14916 men

Nested Case-Control

Food frequency questionnaire and plasma fatty acid measurements

Positive association

RR 3.0 (1.2-7.3)

0.03

Table 2. Studies of a-linolenic acid and prostate cancer risk. Continued

Outcome measurement design

Study/ Reference

n

Study Design

Outcome Measurements

Results (association between ALA and PC)

Relative Risk (RR) or Odds Ratio (OR) (95% CI) of Prostate Cancer Incidence

P Value

Serum-based

Alberg et al 1996

 

25802 (43 cases of PC)

Case-Control

Fatty acid analysis of prediagnostic serum.

No association

 No association

NS

Serum

-based

Harvei et al 1997

141 cases

328 controls

Case-Control

Fatty acid analysis of serum.

Positive association

OR 2.0 (1.1-3.6)

0.02

Serum-based

Newcomer et al 2001

 

 

67 Cases

156 controls

Case-Control

 

Fatty acid analysis of erythrocyte membrane.

Positive association

 

OR 2.6 (1.1-5.8)

0.01

Serum and tissue-based

Godley et al 1996

89 cases

38 controls

Case-Control

Fatty acid analysis of erythrocyte membrane and adipose tissue.

No association

OR of erythrocyte membrane analysis 1.69 (0.54-5.26)

OR of adipose tissue analysis

 

2.73 (0.70-10.61)

0.23

 

 

 

0.18

Tissue-based

 

Freeman et al 2000

63 cases of radical prostatectomy

Case-Control

Fatty acid analysis of resected prostate tissue

Negative

 

0.008



 
custom web design